eXoZymes Inc. Common Stock EXOZ Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $4.25M+14.7% | $3.71M+14.9% | $3.23M+18.1% | $2.73M+26.1% | $2.17M+15.9% | ||
| $5.9M-1.8% | $6.01M+4.0% | $5.78M+7.8% | $5.36M+13.9% | $4.71M+15.9% | ||
| $10.15M+4.5% | $9.72M+7.9% | $9M+11.2% | $8.09M+17.7% | $6.87M+15.9% | ||
| -$10.15M-4.5% | -$9.72M-7.9% | -$9M-11.2% | -$8.09M-17.7% | -$6.87M-15.9% | ||
| $281.5K-22.3% | $362.09K+55.3% | $233.23K+6.6% | $218.69K+94.6% | $112.36K+44.8% | ||
| —— | —— | —— | —— | —— | ||
| -$9.78M-5.5% | -$9.26M-11.1% | -$8.34M-8.2% | -$7.71M-14.9% | -$6.71M-14.5% | ||
| —— | -$105.21K— | —— | —— | —— | ||
| -$9.67M-5.6% | -$9.16M-9.8% | -$8.34M-8.2% | -$7.71M-14.9% | -$6.71M-14.5% | ||
| -$1.14-5.6% | -$1.08-5.9% | -$1.020.0% | -$1.02-6.3% | -$0.96-6.7% | ||
| -$9.86M-4.6% | -$9.43M-8.1% | -$8.72M-11.6% | -$7.81M-18.4% | -$6.6M-16.5% | ||
| -$10.15M-4.5% | -$9.72M-7.9% | -$9M-11.2% | -$8.09M-17.7% | -$6.87M-15.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is eXoZymes Inc. Common Stock's revenue?
- eXoZymes Inc. Common Stock (EXOZ) generated $70.1K in revenue over the trailing twelve months.
- Is eXoZymes Inc. Common Stock profitable?
- eXoZymes Inc. Common Stock is not currently profitable: it reported a net loss of $9.7M over the trailing twelve months, a -2909.1% net margin.
- What is eXoZymes Inc. Common Stock's earnings per share?
- eXoZymes Inc. Common Stock's diluted EPS over the trailing twelve months is $-1.14.
- Where does eXoZymes Inc. Common Stock's income statement data come from?
- Every line is extracted from eXoZymes Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
